{"id":"https://openalex.org/W4410717609","doi":"https://doi.org/10.1177/17588359251339925","title":"Efficacy and safety of rituximab biosimilar (DRL_RI) versus MabThera \u00ae in low-tumor-burden follicular lymphoma: the FLINTER study","display_name":"Efficacy and safety of rituximab biosimilar (DRL_RI) versus MabThera \u00ae in low-tumor-burden follicular lymphoma: the FLINTER study","publication_year":2025,"publication_date":"2025-01-01","ids":{"openalex":"https://openalex.org/W4410717609","doi":"https://doi.org/10.1177/17588359251339925","pmid":"https://pubmed.ncbi.nlm.nih.gov/40421128"},"language":"en","primary_location":{"id":"doi:10.1177/17588359251339925","doi":"https://doi.org/10.1177/17588359251339925","is_oa":true,"landing_page_url":"https://doi.org/10.1177/17588359251339925","pdf_url":null,"source":{"id":"https://openalex.org/S41085503","display_name":"Therapeutic Advances in Medical Oncology","issn_l":"1758-8340","issn":["1758-8340","1758-8359"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Advances in Medical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1177/17588359251339925","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5054430198","display_name":"Narendra Maharaj","orcid":"https://orcid.org/0009-0002-6713-5447","observed_orcids":["https://orcid.org/0009-0002-6713-5447"]},"institutions":[{"id":"https://openalex.org/I4210117495","display_name":"Dr. Reddy's Laboratories (India)","ror":"https://ror.org/01rkxa860","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210117495"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Narendra Maharaj","raw_affiliation_strings":["Biologics Division, Dr. Reddy\u2019s Laboratories Ltd, Bachupally, Hyderabad, Telangana 500090, India"],"raw_orcid":"https://orcid.org/0009-0002-6713-5447","affiliations":[{"raw_affiliation_string":"Biologics Division, Dr. Reddy\u2019s Laboratories Ltd, Bachupally, Hyderabad, Telangana 500090, India","institution_ids":["https://openalex.org/I4210117495"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045684082","display_name":"Dharma Rao Uppada","orcid":"https://orcid.org/0000-0002-4615-465X","observed_orcids":["https://orcid.org/0000-0002-4615-465X"]},"institutions":[{"id":"https://openalex.org/I4210117495","display_name":"Dr. Reddy's Laboratories (India)","ror":"https://ror.org/01rkxa860","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210117495"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Dharma Rao Uppada","raw_affiliation_strings":["Dr. Reddy\u2019s Laboratories Ltd, Hyderabad, Telangana, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dr. Reddy\u2019s Laboratories Ltd, Hyderabad, Telangana, India","institution_ids":["https://openalex.org/I4210117495"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046376263","display_name":"Anand Eswaraiah","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117495","display_name":"Dr. Reddy's Laboratories (India)","ror":"https://ror.org/01rkxa860","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210117495"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Anand Eswaraiah","raw_affiliation_strings":["Dr. Reddy\u2019s Laboratories Ltd, Hyderabad, Telangana, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dr. Reddy\u2019s Laboratories Ltd, Hyderabad, Telangana, India","institution_ids":["https://openalex.org/I4210117495"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115011319","display_name":"Ranjith Kakkattu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117495","display_name":"Dr. Reddy's Laboratories (India)","ror":"https://ror.org/01rkxa860","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210117495"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Ranjith Kakkattu","raw_affiliation_strings":["Dr. Reddy\u2019s Laboratories Ltd, Hyderabad, Telangana, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dr. Reddy\u2019s Laboratories Ltd, Hyderabad, Telangana, India","institution_ids":["https://openalex.org/I4210117495"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Pramod Reddy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117495","display_name":"Dr. Reddy's Laboratories (India)","ror":"https://ror.org/01rkxa860","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210117495"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Pramod Reddy","raw_affiliation_strings":["Dr. Reddy\u2019s Laboratories Ltd, Hyderabad, Telangana, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dr. Reddy\u2019s Laboratories Ltd, Hyderabad, Telangana, India","institution_ids":["https://openalex.org/I4210117495"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005514277","display_name":"V. A. Kalenik","orcid":"https://orcid.org/0000-0001-8629-2830","observed_orcids":["https://orcid.org/0000-0001-8629-2830"]},"institutions":[{"id":"https://openalex.org/I4210131597","display_name":"N.N. Alexandrov National Cancer Centre","ror":"https://ror.org/03ceh9q73","country_code":"BY","type":"facility","lineage":["https://openalex.org/I4210131597"]}],"countries":["BY"],"is_corresponding":false,"raw_author_name":"Volha A. Kalenik","raw_affiliation_strings":["N. N. Alexandrov National Cancer Center, Center of Belarus, Minsk Region, Republic of Belarus"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"N. N. Alexandrov National Cancer Center, Center of Belarus, Minsk Region, Republic of Belarus","institution_ids":["https://openalex.org/I4210131597"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064830159","display_name":"David Belada","orcid":"https://orcid.org/0000-0002-4981-6188","observed_orcids":["https://orcid.org/0000-0002-4981-6188"]},"institutions":[{"id":"https://openalex.org/I4210137570","display_name":"University Hospital Hradec Kr\u00e1lov\u00e9","ror":"https://ror.org/04wckhb82","country_code":"CZ","type":"healthcare","lineage":["https://openalex.org/I4210137570"]}],"countries":["CZ"],"is_corresponding":false,"raw_author_name":"David Belada","raw_affiliation_strings":["Fakultini Nemocnice, Hradec Kralove, IV. Interni Hematologicka Klinika, Hradec Kralove, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fakultini Nemocnice, Hradec Kralove, IV. Interni Hematologicka Klinika, Hradec Kralove, Czech Republic","institution_ids":["https://openalex.org/I4210137570"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ana Oliveira Ramos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]},{"id":"https://openalex.org/I4210143012","display_name":"Duran i Reynals Hospital","ror":"https://ror.org/03qwghy04","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210143012"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Ana Oliveira Ramos","raw_affiliation_strings":["Hematolog\u00eda Cl\u00ednica, Unidad Funcional de Linfomas, ICO\u2014Hospital Duran i Reynals, Hospitalet, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematolog\u00eda Cl\u00ednica, Unidad Funcional de Linfomas, ICO\u2014Hospital Duran i Reynals, Hospitalet, Barcelona, Spain","institution_ids":["https://openalex.org/I4210107147","https://openalex.org/I4210143012"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100780621","display_name":"Jin Seok Kim","orcid":"https://orcid.org/0000-0001-8986-8436","observed_orcids":["https://orcid.org/0000-0001-8986-8436"]},"institutions":[{"id":"https://openalex.org/I193775966","display_name":"Yonsei University","ror":"https://ror.org/01wjejq96","country_code":"KR","type":"education","lineage":["https://openalex.org/I193775966"]},{"id":"https://openalex.org/I2799970807","display_name":"Severance Hospital","ror":"https://ror.org/044kjp413","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I193775966","https://openalex.org/I2799970807","https://openalex.org/I4210160791"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Jin Seok Kim","raw_affiliation_strings":["Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seodaemun-gu, Seoul, Korea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seodaemun-gu, Seoul, Korea","institution_ids":["https://openalex.org/I193775966","https://openalex.org/I2799970807"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5019615907","display_name":"Yauheni Valerievich Baranau","orcid":"https://orcid.org/0000-0003-4582-5615","observed_orcids":["https://orcid.org/0000-0003-4582-5615"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yauheni V. Baranau","raw_affiliation_strings":["Minsk City Clinical Oncology Center, Minsk, Republic of Belarus"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Minsk City Clinical Oncology Center, Minsk, Republic of Belarus","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5054430198"],"corresponding_institution_ids":["https://openalex.org/I4210117495"],"apc_list":{"value":2800,"currency":"USD","value_usd":2800},"apc_paid":{"value":2800,"currency":"USD","value_usd":2800},"fwci":0.5881,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.65326451,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"17","issue":null,"first_page":"17588359251339925","last_page":"17588359251339925"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9750999808311462,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.01679999940097332,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0038999998942017555,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rituximab-biosimilar","display_name":"rituximab biosimilar","score":0.9850000143051147},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9610000252723694},{"id":"https://openalex.org/keywords/follicular-lymphoma","display_name":"follicular lymphoma","score":0.8230000138282776},{"id":"https://openalex.org/keywords/cd20-positive-lymphoma","display_name":"CD20-positive lymphoma","score":0.8790000081062317},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.9089999794960022},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.6489999890327454},{"id":"https://openalex.org/keywords/b-cell-depletion","display_name":"B-cell depletion","score":0.8629999756813049},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.75},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.75},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.722000002861023}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.917449951171875},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.7081618905067444},{"id":"https://openalex.org/C2777058707","wikidata":"https://www.wikidata.org/wiki/Q123251","display_name":"Follicular lymphoma","level":3,"score":0.5881921052932739},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.5585203170776367},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5270897150039673},{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.49486011266708374},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.46592921018600464},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.46546459197998047},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.46312958002090454},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.42320355772972107},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.41624805331230164},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4149148166179657},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.39120516180992126},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3490263819694519},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.31106725335121155},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.21416932344436646},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.17067420482635498},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.1706390082836151}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.1177/17588359251339925","doi":"https://doi.org/10.1177/17588359251339925","is_oa":true,"landing_page_url":"https://doi.org/10.1177/17588359251339925","pdf_url":null,"source":{"id":"https://openalex.org/S41085503","display_name":"Therapeutic Advances in Medical Oncology","issn_l":"1758-8340","issn":["1758-8340","1758-8359"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Advances in Medical Oncology","raw_type":"journal-article"},{"id":"pmid:40421128","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40421128","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic advances in medical oncology","raw_type":"Journal Article"},{"id":"pmh:oai:europepmc.org:10913943","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/12104602","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:12104602","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/12104602","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Ther Adv Med Oncol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:9f4f99a064ff40ae99f4b213f5b29cf0","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/9f4f99a064ff40ae99f4b213f5b29cf0","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Therapeutic Advances in Medical Oncology, Vol 17 (2025)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1177/17588359251339925","doi":"https://doi.org/10.1177/17588359251339925","is_oa":true,"landing_page_url":"https://doi.org/10.1177/17588359251339925","pdf_url":null,"source":{"id":"https://openalex.org/S41085503","display_name":"Therapeutic Advances in Medical Oncology","issn_l":"1758-8340","issn":["1758-8340","1758-8359"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Advances in Medical Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.7699999809265137,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F207316933","display_name":"Dr. Reddy's Laboratories","ror":"https://ror.org/01rkxa860"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W1912693401","https://openalex.org/W1979080264","https://openalex.org/W1999130958","https://openalex.org/W2030638302","https://openalex.org/W2108669049","https://openalex.org/W2116895103","https://openalex.org/W2119147717","https://openalex.org/W2125354192","https://openalex.org/W2136326451","https://openalex.org/W2166846242","https://openalex.org/W2481029616","https://openalex.org/W2608724752","https://openalex.org/W2898856153","https://openalex.org/W2992331654","https://openalex.org/W2993964230","https://openalex.org/W3006227285","https://openalex.org/W3092483376","https://openalex.org/W3197276378","https://openalex.org/W4255164806","https://openalex.org/W4308552277","https://openalex.org/W6978996086"],"related_works":["https://openalex.org/W2062566755","https://openalex.org/W2167103668","https://openalex.org/W2084396664","https://openalex.org/W2761932222","https://openalex.org/W2094454764","https://openalex.org/W2488602574","https://openalex.org/W2028043880","https://openalex.org/W2094591637","https://openalex.org/W2944081921","https://openalex.org/W2113605807"],"abstract_inverted_index":{"Background":[0],"and":[1,24,33,49,62,114,129,188,238,252],"objectives:":[2],")":[3],"in":[4,182,203],"patients":[5],"with":[6,30,147,206,232],"previously":[7],"untreated":[8],"Stage":[9],"II-IV,":[10],"CD20-positive,":[11],"low-tumor-burden":[12],"follicular":[13],"lymphoma":[14],"(LTB-FL).":[15],"This":[16,244],"study":[17,224],"also":[18],"evaluated":[19],"safety,":[20,124,186,234],"immunogenicity,":[21,125,187,235],"rituximab":[22],"concentrations,":[23,128,237],"pharmacodynamics":[25],"(PD)":[26],"of":[27,40,118,150,184,213,228],"DRL_RI":[28,143,219,229],"compared":[29],"MabThera.":[31,221],"Design":[32],"methods:":[34],"=":[35],"155)":[36],"as":[37],"intravenous":[38],"infusions":[39],"375":[41],"mg/m\u00b2":[42],"weekly":[43],"for":[44,99,142,171,218],"4":[45],"weeks":[46,53],"(induction":[47],"period),":[48],"thereafter":[50],"every":[51],"8":[52],"from":[54],"Week":[55,58,66,80,136],"12":[56],"to":[57,79,135,155,160,210,230],"36":[59],"(maintenance":[60],"treatment),":[61],"followed":[63],"up":[64,78,134],"till":[65],"52.":[67],"The":[68,132,223],"primary":[69],"end":[70,110,175],"point":[71],"was":[72,90,102,138,246],"best":[73],"overall":[74,122],"response":[75],"rate":[76],"(BORR)":[77],"28":[81,137],"based":[82],"on":[83],"blinded":[84],"independent":[85],"central":[86],"review.":[87],"Efficacy":[88],"equivalence":[89,106,227],"demonstrated":[91,225],"if":[92],"the":[93,104,163],"two-sided":[94],"90%":[95],"confidence":[96],"interval":[97],"(CI)":[98],"BORR":[100,133],"difference":[101,149],"within":[103,162],"prespecified":[105,164],"margin":[107],"(\u00b117%).":[108],"Secondary":[109],"points":[111],"included":[112],"objective":[113],"complete":[115],"responses,":[116],"duration":[117],"response,":[119],"progression-free":[120],"survival,":[121,123],"mean":[126,189],"serum":[127,190,236],"PD.":[130],"Results:":[131],"80.2%":[139],"versus":[140,144,215,220],"79.4%":[141],"MabThera":[145],"group;":[146],"a":[148,207],"0.89%":[151],"(90%":[152],"CI:":[153,158],"-6.67":[154],"8.48;":[156],"95%":[157],"-8.05":[159],"9.93":[161],"margin).":[165],"Both":[166],"treatment":[167],"groups":[168],"were":[169,180,192],"comparable":[170,233],"all":[172],"secondary":[173],"efficacy":[174,226],"points.":[176],"Treatment-emergent":[177],"adverse":[178],"events":[179],"reported":[181],"68.6%":[183],"patients;":[185],"concentrations":[191],"similar":[193],"between":[194,240],"groups.":[195,241],"Peripheral":[196],"B-cell":[197,211],"counts":[198],"declined":[199],"below":[200],"quantifiable":[201],"limits":[202],"most":[204],"patients,":[205],"median":[208],"time":[209],"depletion":[212],"6.9":[214],"7.0":[216],"days":[217],"Conclusion:":[222],"MabThera;":[231],"PD":[239],"Trial":[242],"registration:":[243],"trial":[245],"registered":[247],"at":[248],"ClinicalTrials.gov":[249],"identifier:":[250],"NCT03976102":[251],"EudraCT":[253],"(2018-004223-36).":[254]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2025-05-25T00:00:00"}